FDA adds warning to Ozempic, Mounjaro and other GLP-1 labels
(By Alexandra Murphy for Becker’s Hospital Review ) The FDA has updated the labels for all GLP-1 receptor agonists, including
Read moreA trusted source for Medicare news and education from the AMAC Foundation.
(By Alexandra Murphy for Becker’s Hospital Review ) The FDA has updated the labels for all GLP-1 receptor agonists, including
Read more(By Elizabeth Williams, Robin Rudowitz, and Clea Bell for The Kaiser Family Foundation Published: Nov 04, 2024) GLP-1 (glucagon-like peptide-1)
Read more(By Rylee Wilson for Becker’s Hospital Review ) Medicare spending could increase between $3.1 billion and $6.1 billion annually if
Read more(By Tammie Smith for The Kaiser Family Foundation published August 5, 2024) ACA Marketplace insurers are proposing a median premium
Read more(By Rylee Wilson for Becker’s Hospital Review ) Premiums for plans on the ACA marketplace will rise 7% on average
Read more